Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users


Por: Bouso, JC, Fabregas, JM, Antonijoan, RM, Rodriguez-Fornells, A, Riba, J

Publicada: 1 dic 2013
Resumen:
Background Ayahuasca, a South American psychotropic plant tea containing the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine, has been shown to increase regional cerebral blood flow in prefrontal brain regions after acute administration to humans. Despite interactions at this level, neuropsychological studies have not found cognitive deficits in abstinent long-term users. Here, we wished to investigate the effects of acute ayahuasca intake on neuropsychological performance, specifically on working memory and executive function. Twenty-four ayahuasca users (11 long-term experienced users and 13 occasional users) were assessed in their habitual setting using the Stroop, Sternberg, and Tower of London tasks prior to and following ayahuasca intake. Errors in the Sternberg task increased, whereas reaction times in the Stroop task decreased and accuracy was maintained for the whole sample following ayahuasca intake. Interestingly, results in the Tower of London showed significantly increased execution and resolution times and number of movements for the occasional but not the experienced users. Additionally, a correlation analysis including all subjects showed that impaired performance in the Tower of London was inversely correlated with lifetime ayahuasca use. Acute ayahuasca administration impaired working memory but decreased stimulus-response interference. Interestingly, detrimental effects on higher cognition were only observed in the less experienced group. Rather than leading to increased impairment, greater prior exposure to ayahuasca was associated with reduced incapacitation. Compensatory or neuromodulatory effects associated with long-term ayahuasca intake could underlie preserved executive function in experienced users.

Filiaciones:
Bouso, JC:
 IIB St Pau, St Pau Inst Biomed Res, Barcelona 08025, Spain

 Hosp Santa Creu & Sant Pau, Ctr Invest Med Servei Farmacol Clin, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Farmacol & Terapeut, Catalonia, Spain

 ICEERS Int Ctr Ethnobot Educ Res & Serv, Halsteren, Netherlands

Fabregas, JM:
 Ctr Invest & Tractament Addicc, Barcelona 08039, Spain

 Inst Etnospicol Amazon Aplicada, Manaus, Amazonas, Brazil

Antonijoan, RM:
 Hosp Santa Creu & Sant Pau, Ctr Invest Med Servei Farmacol Clin, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Farmacol & Terapeut, Catalonia, Spain

 CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain

Rodriguez-Fornells, A:
 Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Lhospitalet De Llobregat 08097, Spain

 Univ Barcelona, Dept Basic Psychol, Barcelona 08035, Spain

 ICREA, Catalan Inst Res & Adv Studies, Barcelona, Spain

Riba, J:
 IIB St Pau, St Pau Inst Biomed Res, Barcelona 08025, Spain

 Hosp Santa Creu & Sant Pau, Ctr Invest Med Servei Farmacol Clin, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Farmacol & Terapeut, Catalonia, Spain

 CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain
ISSN: 00333158





PSYCHOPHARMACOLOGY
Editorial
SPRINGER, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Alemania
Tipo de documento: Article
Volumen: 230 Número: 3
Páginas: 415-424
WOS Id: 000327090500008
ID de PubMed: 23793226

MÉTRICAS